Kaskela Law LLC announces that it is investigating AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of the Company’s long-term investors. The investigation seeks to determine whether the members of AdaptHealth’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with alleged corporate misconduct.
Recently a securities fraud complaint was filed against AdaptHealth on behalf of certain investors who purchased shares of AdaptHealth’s common stock between November 8, 2019 and July 16, 2021. According to the complaint, during that time period AdaptHealth made a series of materially false and misleading statements to investors about the Company’s business, operations, prospects, and leadership.
As detailed in the complaint, on April 13, 2021, AdaptHealth disclosed that it had put its Co-CEO “on unpaid leave” after claiming that it had “learned that authorities in Denmark have formally charged [him] with alleged tax fraud arising from certain past private activity.” Following this news, AdaptHealth’s stock price fell $7.30 per share, or nearly 20% in value.
Subsequently, on July 19, 2021, Jehoshaphat Research published a report alleging that AdaptHealth’s organic revenue growth had stalled, and that the Company had intentionally inflated and obscured its organic revenue growth figures. Following the release of the Jehoshaphat Report, AdaptHealth’s stock price fell an additional $1.51 per share, or nearly 6% in value.
Current AdaptHealth shareholders who purchased or acquired shares of the Company’s common stock prior to January 1, 2020 are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/adapthealth-corp/ , for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $150 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
This notice may constitute attorney advertising in certain jurisdictions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221013005418/en/
Contacts
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
